论文部分内容阅读
目的 :探讨康复新液联合法莫替丁对消化性溃疡的治疗作用。方法 :16 1例经内镜确诊的消化性溃疡患者均予 1 3C尿素呼气试验 ,随机分为 2组 ,治疗组 82例 ,予康复新液与法莫替丁联用 ;对照组 79例 ,予法莫替丁与丽珠得乐联用 ,疗程均为 4周。对幽门螺杆菌 (Hp)阳性者加用阿莫西林和甲硝唑 1周。结果 :治疗组溃疡痊愈率为 87.80 % (72 / 82 ) ,1年内复发率 11.11% (8/ 72 ) ;对照组分别为 73.4 2 % (5 8/ 79)及 2 5 .86 % (15 / 5 8)。两组比较差异有显著性意义 (P <0 .0 5 )。而对 Hp根除率两组差异无显著性意义 (P >0 .0 5 )。在治疗过程中 ,两组均未见明显不良反应。结论 :康复新液联用法莫替丁治疗消化性溃疡的疗效确切 ,副作用少 ,可广泛用于临床。
Objective: To investigate the therapeutic effect of Kangfuxin Solution combined with famotidine on peptic ulcer. Methods: One hundred and sixteen patients with peptic ulcer diagnosed by endoscopy were assigned to 1 C 3 C urea breath test. They were randomly divided into 2 groups, 82 in the treatment group, and Kangfuxinye combined with famotidine. In the control group, 79 patients , To famotidine and Livzon music together, treatment are 4 weeks. For Helicobacter pylori (Hp) positive plus amoxicillin and metronidazole for 1 week. Results: The cure rate was 87.80% (72/82) in the treatment group and 11.11% (8/72) in 1 year. The control group was 73.4 2% (5/79) and 25.86% (15 / 5 8). There was significant difference between the two groups (P <0.05). There was no significant difference between the two groups (P> 0.05). In the course of treatment, no obvious adverse reactions were observed in both groups. Conclusion: Kangfuxin solution combined with famotidine in the treatment of peptic ulcer is effective and has few side effects. It can be widely used in clinic.